The Latest Breaking News from MASI

Masimo could take a bite out of Apple's sales, an analyst said Friday as MASI stock surged after winning a patent battle.

It could take Masimo months to regain its footing, an analyst said Tuesday as investors hammered MASI stock on a massive sales miss.

All stories are to be approved by the government before broadcast on the SIBC, prompting grave concerns about press freedom

Chinese Foreign Minister Wang Yi's whirlwind visit to the Pacific has seen press conferences and media access heavily restricted, highlighting the growing threat to journalism in the region.

Masimo Corp's (NASDAQ:MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700 in Q1 of 2022. The adjusted operating margin remained unchanged at 22.9%. The company reported…

The probability of aggressive interest rate increases by the Fed later this year, and the Ukraine-Russia war, have weighed on the stock market so far this year. However, April has traditionally been one of the best months of the year for stocks. Therefore, we think the recent market dip could…

Following a disappointing stock market performance since the beginning of the year, progress in peace talks between Russia and Ukraine and an expected steady economic recovery despite the likelihood of more interest rate hikes have improved investor sentiment of late. Therefore, we think it could be wise to bet on…

Masimo Corp (NASDAQ:MASI) expects Q1 FY22 product revenue of $285 million - $315 million, lower than expected. Shortages of critical components and other supply chain issues, including freight carrier delays, have led to lower-than-expected sales in the first quarter. Related:  Joe Kiani, Chairman, and CEO, said, "In prior quarters, we were able…

Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: